Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Microbiology
Fingerprint
Dive into the research topics where Weina Sun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 29 Article
-
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
Carreño, J. M., Raskin, A., Singh, G., Tcheou, J., Kawabata, H., Gleason, C., Srivastava, K., Vigdorovich, V., Dambrauskas, N., Gupta, S. L., González Domínguez, I., Martinez, J. L., Slamanig, S., Sather, D. N., Raghunandan, R., Wirachwong, P., Muangnoicharoen, S., Pitisuttithum, P., Wrammert, J., Suthar, M. S., & 5 others, 15 Feb 2023, In: Science Translational Medicine. 15, 683, p. eabo2847Research output: Contribution to journal › Article › peer-review
Open Access -
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
Bliss, C. M., Freyn, A. W., Caniels, T. G., Leyva-Grado, V. H., Nachbagauer, R., Sun, W., Tan, G. S., Gillespie, V. L., McMahon, M., Krammer, F., Hill, A. V. S., Palese, P. & Coughlan, L., 4 May 2022, In: Molecular Therapy. 30, 5, p. 2024-2047 24 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants
Duty, J. A., Kraus, T., Zhou, H., Zhang, Y., Shaabani, N., Yildiz, S., Du, N., Singh, A., Miorin, L., Li, D., Stegman, K., Ophir, S., Cao, X., Atanasoff, K., Lim, R., Mena, I., Bouvier, N. M., Kowdle, S., Carreño, J. M., Rivero-Nava, L., & 29 others, 14 Oct 2022, In: Med. 3, 10, p. 705-721.e11Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
Zhu, X., Han, J., Sun, W., Puente-Massaguer, E., Yu, W., Palese, P., Krammer, F., Ward, A. B. & Wilson, I. A., 24 May 2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 21, e2200821119.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam
Duc Dang, A., Dinh Vu, T., Hai Vu, H., Thanh Ta, V., Thi Van Pham, A., Thi Ngoc Dang, M., Van Le, B., Huu Duong, T., Van Nguyen, D., Lawpoolsri, S., Chinwangso, P., McLellan, J. S., Hsieh, C. L., Garcia-Sastre, A., Palese, P., Sun, W., Martinez, J. L., Gonzalez-Dominguez, I., Slamanig, S., Manuel Carreño, J., & 13 others, 9 Jun 2022, In: Vaccine. 40, 26, p. 3621-3632 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Press/Media
-
Australia Patent: Laboratorio Avi-Mex de C.V., Icahn School of Medicine at Mount Sinai File Application for 'Recombinant vaccine against covid-19 based on a paramyxovirus viral vector'
Florian Krammer, Peter Palese & Weina Sun
16/12/22
1 item of Media coverage
Press/Media
-
Mount Sinai Announces CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics Targeting Pandemic Threats and Diseases
Florian Krammer,, Adolfo Garcia-Sastre,, Peter Palese & Weina Sun
9/08/22
9 items of Media coverage
Press/Media
-
Mount Sinai Announces CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics Targeting Pandemic Threats and Diseases.
Florian Krammer,, Adolfo Garcia-Sastre,, Peter Palese & Weina Sun
9/08/22
1 item of Media coverage
Press/Media
-
Mount Sinai Announces the Formation of CastleVax a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need
Florian Krammer,, Peter Palese & Weina Sun
9/08/22
1 item of Media coverage
Press/Media
-
Patria Vaccine is already a world brand
Florian Krammer,, Peter Palese & Weina Sun
5/01/22
1 item of Media coverage
Press/Media